Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b

Multiple Sclerosis : Clinical and Laboratory Research
J Steven AlexanderAlireza Minagar

Abstract

Interferon-beta1b (IFN-beta1b), an effective treatment for multiple sclerosis (MS), lessens disease severity in MS patients. However, the mechanisms of its immunoregulatory and anti-inflammatory effects in MS remain only partially understood. Matrix metalloproteinases (MMP) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) are involved in blood brain barrier disruption and formation of MS lesions. Th1/Th17 cytokines e.g. interleukins IL-12p40, IL-17, and IL-23, are associated with MS disease activity and are significant players in pathogenesis of MS. During a 1-year prospective study, we serially measured serum MMP-8, MMP-9, TIMP-1, IL-12p40, IL-17, and IL-23 in 24 patients with relapsing-remitting MS. We compared the results to clinical course and to brain magnetic resonance imaging. IFN-beta1b decreased serum MMP-8 and MMP-9 (not TIMP-1). The sustained treatment with IFN-beta1b attenuated the pro-inflammatory environment by significantly reducing the serum IL-12p40, IL-23, and showed a trend for decreasing IL-17. Decreased serum MMP-8, MMP-9, IL-12 and IL-23 levels were correlated with a decrease in the number of contrast-enhanced T2-weighted lesions. Early treatment of MS with IFN-beta1b may stabilize clinical dise...Continue Reading

References

Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·T NaseerQ Hamid
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Jan 29, 1998·The New England Journal of Medicine·S G Waxman
May 21, 1999·Multiple Sclerosis : Clinical and Laboratory Research·D MatuseviciusH Link
Oct 12, 1999·Multiple Sclerosis : Clinical and Laboratory Research·C Rohowsky-KochanS D Cook
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Nov 18, 2000·The New England Journal of Medicine·W I McDonald
Mar 7, 2003·Journal of Neuroimmunology·Carlo AvolioMaria Trojano
May 24, 2003·Brain : a Journal of Neurology·Inge NelissenGhislain Opdenakker
Nov 13, 2004·The New England Journal of Medicine·Peter J MannonUNKNOWN Anti-IL-12 Crohn's Disease Study Group
Jan 20, 2005·The Journal of Experimental Medicine·Claire L LangrishDaniel J Cua
Mar 3, 2006·The New England Journal of Medicine·Elliot M FrohmanCedric S Raine
May 3, 2006·Journal of Clinical Immunology·Maya RamYehuda Shoenfeld
May 4, 2006·Journal of Leukocyte Biology·Angela J FaheyCris S Constantinescu
Jul 28, 2006·Neurology·Jorge CorrealeWendy Gilmore
Jan 5, 2007·Annual Review of Immunology·Casey T WeaverLaurie E Harrington
Apr 28, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R K ZabadV W Yong
Aug 24, 2007·Acta Neurologica Scandinavica·A DresselF Weber
Feb 5, 2008·The Journal of Biological Chemistry·Alicia R FolguerasCarlos López-Otín
May 14, 2008·Archives of Neurology·Manjit BraitchCris S Constantinescu
Aug 19, 2008·Gastroenterology·William J SandbornUNKNOWN Ustekinumab Crohn's Disease Study Group
Feb 18, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M KhademiT Olsson
Mar 11, 2009·Expert Review of Neurotherapeutics·Erin E Longbrake, Michael K Racke
Apr 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susanta MondalKalipada Pahan
Apr 18, 2009·Microbes and Infection·Pierre Miossec
May 29, 2009·Annals of Neurology·Luca DurelliFrancesco Novelli
Jul 3, 2009·Expert Opinion on Biological Therapy·Xinaida Taligare LimaHermenio Cavalcante Lima

❮ Previous
Next ❯

Citations

Jun 28, 2011·Current Neurology and Neuroscience Reports·Manuel Comabella, Koen Vandenbroeck
Sep 5, 2013·Acta neurologica Belgica·Mohammad A JavaidZeeshan Sheikh
Nov 16, 2013·BMC Medicine·Jonathan S AlexanderAlireza Minagar
Oct 6, 2011·Journal of Neuroinflammation·Bianca Weinstock-GuttmanMurali Ramanathan
Aug 2, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kiel TelesfordLloyd H Kasper
Jul 30, 2014·Neurochemical Research·Xiao-Fang LiuHuan Yang
Oct 1, 2015·Expert Opinion on Drug Metabolism & Toxicology·Harald HegenFlorian Deisenhammer
Jul 26, 2012·Neurological Research·Alireza MinagarJ Steven Alexander
Jul 23, 2016·Journal of Immunology Research·Igor Z BarjaktarevicRobert J Kaner
Aug 15, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R S RaoP Pandhi
Mar 25, 2015·Progress in Neurobiology·Giulia MallucciStefano Pluchino
Jan 11, 2012·Journal of Neuroimmunology·Ying-Chun ChenQi Cheng
Mar 3, 2012·Journal of Neuroimmunology·Leah M Alabanza, Margaret S Bynoe
Feb 11, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Alessandro TrentiniUNKNOWN Emilia-Romagna network for Multiple Sclerosis (ERMES) study group
Jan 21, 2017·Multiple Sclerosis and Related Disorders·Ana ValadoInês Baldeiras
Aug 6, 2015·Journal of Lipid Research·Kelly FellowsMurali Ramanathan
Dec 7, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Aiden HaghikiaAndrew Chan
Jan 21, 2012·European Neurology·Fredrik RomiNils Erik Gilhus
May 10, 2011·FEBS Letters·Catherine LarochelleAlexandre Prat
Sep 27, 2019·Molecular Biology Reports·Rahim Heidari Barchi NezhadMohammad Reza Mirzaei
Dec 14, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Anisha Doshi, Jeremy Chataway
Dec 3, 2017·Clinical Medicine : Journal of the Royal College of Physicians of London·Anisha Doshi, Jeremy Chataway
Sep 14, 2019·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Miaomiao HouXinyi Li
Nov 1, 2016·Journal of Neurochemistry·Behnam VafadariLeszek Kaczmarek
Nov 29, 2020·Glia·Sofia Pereira das NevesFernanda Marques
Feb 25, 2021·Acta Neurologica Scandinavica·Christina ZhukovskyJoachim Burman
May 6, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·George J A Ten BoschJon D Laman
Apr 13, 2015·ACS Biomaterials Science & Engineering·Susanne Müller-Herrmann, Thomas Scheibel
Sep 19, 2014·Journal of Proteome Research·Sanna ByströmJochen M Schwenk
Mar 15, 2011·Experimental Cell Research·Richard A Rudick, Susan E Goelz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.